Status: Not yet recruiting
Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese Participants
Use these resources to provide understandable information about this study to patients, families, and health care providers:
Participants needed: 90
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Shanghai JMT-Bio Inc.Updated: Sep 25, 2026Locations: 1
Eligibility criteria
Age 18~65 (including threshold values), male or female participants; [+3]